Corporate Overview

BioAgri is a biopharmaceutical company capitalizing on the latest transgenic animal technology: linker-based sperm-mediated gene transfer (LB-SMGT). LB-SMGT is a simple and economical method to make transgenic chickens that can be used to produce large quantities of low-cost therapeutic proteins from eggs for the benefit of medicine. Our business targets the enormous multi-billion-dollar biopharmaceutical market.   We are headquartered in Los Angeles, California, USA, and have two facilities for biomanufacturing human therapeutic proteins from transgenic chicken eggs. A cGMP manufacturing plant with SPF standard is operational.